Literature DB >> 19122877

Chemopreventive doses of methylselenocysteine alter circadian rhythm in rat mammary tissue.

Xun Zhang1, Helmut Zarbl.   

Abstract

It is known that organic forms of selenium inhibit chemically induced rat mammary carcinogenesis, although the molecular basis remains to be elucidated. To identify signaling pathways involved in carcinogenesis that are also modulated by methylselenocysteine, we compared the global gene expression profiles in mammary tissues from pubescent female rats maintained on a selenium-supplemented (3 ppm) diet with those on a standardized diet after N-nitroso-N-methylurea. Whereas the selenium-enriched diet altered the steady-state levels of genes involved in various cellular functions, the most dramatic effect was the coordinated changes in the expression of multiple genes that regulate circadian rhythm. Normal mammary tissue of rats fed a standardized diet showed little circadian oscillation relative to liver tissue. By contrast, mammary tissue of rats maintained on the selenium-enriched diet showed a progressive, time-dependent increase in the expression of circadian gene Per2 and circadian-regulated transcription factor DBP. Our results further showed that the expression of Per2 and DBP mRNAs was significantly decreased in mammary tumors arising in rats on the selenium-enriched diet, but not in tumors of rats on the control diet, suggesting that selenium-induced elevation in the expression of circadian genes was incompatible with mammary carcinogenesis. Given the previously reported role of Per2 as a tumor suppressor, these observations suggest that Per2 is an important target of methylselenocysteine during chemoprevention in N-nitroso-N-methylurea-induced rat mammary carcinogenesis, and for the first time provide a link between chemoprevention and circadian rhythm.

Entities:  

Keywords:  chemoprevention; circadian; mammary carcinogenesis; microarray; selenium

Mesh:

Substances:

Year:  2008        PMID: 19122877      PMCID: PMC2519612          DOI: 10.1158/1940-6207.CAPR-08-0036

Source DB:  PubMed          Journal:  Cancer Prev Res (Phila)        ISSN: 1940-6215


  51 in total

1.  Deregulated expression of the PER1, PER2 and PER3 genes in breast cancers.

Authors:  Shou-Tung Chen; Kong-Bung Choo; Ming-Feng Hou; Kun-Tu Yeh; Shou-Jen Kuo; Jan-Gowth Chang
Journal:  Carcinogenesis       Date:  2005-03-24       Impact factor: 4.944

2.  Shift work, light at night, and breast cancer on Long Island, New York.

Authors:  Erin S O'Leary; Elinor R Schoenfeld; Richard G Stevens; Geoffrey C Kabat; Kevin Henderson; Roger Grimson; Marilie D Gammon; M Cristina Leske
Journal:  Am J Epidemiol       Date:  2006-06-15       Impact factor: 4.897

Review 3.  Molecular chemoprevention by selenium: a genomic approach.

Authors:  Karam El-Bayoumy; Raghu Sinha
Journal:  Mutat Res       Date:  2005-08-15       Impact factor: 2.433

4.  Abnormal expression of period 1 (PER1) in endometrial carcinoma.

Authors:  Kun-Tu Yeh; Ming-Yu Yang; Ta-Chih Liu; Jui-Chang Chen; Wen-Ling Chan; Sheng-Fung Lin; Jan-Gowth Chang
Journal:  J Pathol       Date:  2005-05       Impact factor: 7.996

Review 5.  Risk of breast cancer after night- and shift work: current evidence and ongoing studies in Denmark.

Authors:  Johnni Hansen
Journal:  Cancer Causes Control       Date:  2006-05       Impact factor: 2.506

Review 6.  Circadian disruption, shift work and the risk of cancer: a summary of the evidence and studies in Seattle.

Authors:  Scott Davis; Dana K Mirick
Journal:  Cancer Causes Control       Date:  2006-05       Impact factor: 2.506

Review 7.  Tumor suppression by the mammalian Period genes.

Authors:  Cheng Chi Lee
Journal:  Cancer Causes Control       Date:  2006-05       Impact factor: 2.506

8.  Circadian clock and cell cycle gene expression in mouse mammary epithelial cells and in the developing mouse mammary gland.

Authors:  Richard P Metz; Xiaoyu Qu; Brian Laffin; David Earnest; Weston W Porter
Journal:  Dev Dyn       Date:  2006-01       Impact factor: 3.780

9.  High-Throughput GoMiner, an 'industrial-strength' integrative gene ontology tool for interpretation of multiple-microarray experiments, with application to studies of Common Variable Immune Deficiency (CVID).

Authors:  Barry R Zeeberg; Haiying Qin; Sudarshan Narasimhan; Margot Sunshine; Hong Cao; David W Kane; Mark Reimers; Robert M Stephens; David Bryant; Stanley K Burt; Eldad Elnekave; Danielle M Hari; Thomas A Wynn; Charlotte Cunningham-Rundles; Donn M Stewart; David Nelson; John N Weinstein
Journal:  BMC Bioinformatics       Date:  2005-07-05       Impact factor: 3.169

10.  Transcriptional oscillation of canonical clock genes in mouse peripheral tissues.

Authors:  Takuro Yamamoto; Yasukazu Nakahata; Haruhiko Soma; Makoto Akashi; Takayoshi Mamine; Toru Takumi
Journal:  BMC Mol Biol       Date:  2004-10-09       Impact factor: 2.946

View more
  8 in total

Review 1.  Circadian rhythm disruption in cancer biology.

Authors:  Christos Savvidis; Michael Koutsilieris
Journal:  Mol Med       Date:  2012-12-06       Impact factor: 6.354

2.  In Vitro Bioluminescence Assay to Characterize Circadian Rhythm in Mammary Epithelial Cells.

Authors:  Mingzhu Fang; Hwan-Goo Kang; Youngil Park; Brian Estrella; Helmut Zarbl
Journal:  J Vis Exp       Date:  2017-09-28       Impact factor: 1.355

3.  Methylselenocysteine resets the rhythmic expression of circadian and growth-regulatory genes disrupted by nitrosomethylurea in vivo.

Authors:  Ming Zhu Fang; Xun Zhang; Helmut Zarbl
Journal:  Cancer Prev Res (Phila)       Date:  2010-04-27

4.  Selenium, but not lycopene or vitamin E, decreases growth of transplantable dunning R3327-H rat prostate tumors.

Authors:  Brian L Lindshield; Nikki A Ford; Kirstie Canene-Adams; Alan M Diamond; Matthew A Wallig; John W Erdman
Journal:  PLoS One       Date:  2010-04-29       Impact factor: 3.240

5.  Sleep interruption associated with house staff work schedules alters circadian gene expression.

Authors:  Ming Zhu Fang; Pamela Ohman-Strickland; Kathie Kelly-McNeil; Howard Kipen; Benjamin F Crabtree; Jenny Pan Lew; Helmut Zarbl
Journal:  Sleep Med       Date:  2015-07-23       Impact factor: 3.492

6.  Selenium is a modulator of circadian clock that protects mice from the toxicity of a chemotherapeutic drug via upregulation of the core clock protein, BMAL1.

Authors:  Yan Hu; Mary L Spengler; Karen K Kuropatwinski; Maria Comas-Soberats; Marilyn Jackson; Mikhail V Chernov; Anatoly S Gleiberman; Natalia Fedtsova; Youcef M Rustum; Andrei V Gudkov; Marina P Antoch
Journal:  Oncotarget       Date:  2011-12

7.  Uncoupling genotoxic stress responses from circadian control increases susceptibility to mammary carcinogenesis.

Authors:  Mingzhu Fang; Pamela A Ohman Strickland; Hwan-Goo Kang; Helmut Zarbl
Journal:  Oncotarget       Date:  2017-05-16

8.  Enhancement of NAD⁺-dependent SIRT1 deacetylase activity by methylselenocysteine resets the circadian clock in carcinogen-treated mammary epithelial cells.

Authors:  Mingzhu Fang; Wei-Ren Guo; Youngil Park; Hwan-Goo Kang; Helmut Zarbl
Journal:  Oncotarget       Date:  2015-12-15
  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.